Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
01/18/1994 | US5280107 Using an anioic exchanger |
01/18/1994 | US5280106 Pentapeptide; collagenase inhibitor |
01/18/1994 | US5280023 Containing a mixture of estrogen and gestagen |
01/18/1994 | US5280014 Treatment of obesity and essential hypertension and related disorders |
01/18/1994 | US5279966 Isolated vertebrate nucleic acid |
01/18/1994 | US5279960 Cloned genes; eluting protective immune response when administed to avian host |
01/18/1994 | US5279956 Polypeptide inhibits active protein C amidolytic activity |
01/18/1994 | US5279941 Determination of endometrial receptivity toward embryo implantation |
01/18/1994 | US5279836 Topical application |
01/18/1994 | US5279826 Prophylactic/therapeutic composition for disseminated intravascular coagulation, chronic respiratory tract infectious disease or chronic bronchitis |
01/18/1994 | US5279825 Adhesive consisting of fibrin and collagenase |
01/18/1994 | US5279824 Pharmaceutical formulation containing heparin and endo-beta-glucuronidase, useful for the treatment of thrombosis |
01/18/1994 | US5279823 Purified forms of DNASE |
01/18/1994 | US5279812 Radiolabeled anticoagulant peptides |
01/18/1994 | CA2099346A1 Lipid metabolism improving composition |
01/18/1994 | CA2074156A1 Yeast-derived epidermal growth factor/urogastrone-like products |
01/18/1994 | CA1326326C Platelet-aggregation inhibitors |
01/18/1994 | CA1326216C Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins |
01/18/1994 | CA1326211C Antibiotic solutions and the lyophilization thereof |
01/18/1994 | CA1326210C Nasal formulations and a process for preparation thereof |
01/18/1994 | CA1326209C Glass microbeads having bacteriostatic properties and process for manufacturing such microbeads |
01/15/1994 | CA2100377A1 Bispecific antibody |
01/14/1994 | CA2099476A1 Medicaments comprising glicentin as active ingredient |
01/13/1994 | DE4228162C1 Verfahren zum Ersetzen homologer Genabschnitte aus Säugern in der Keimbahn von nicht-menschlichen Säugern A method of replacing homologous gene segments from mammalian germline of non-human mammals |
01/13/1994 | DE4222385A1 Isolating substances which inhibit binding of ligands to low-density lipoprotein receptors - comprises incubating LDL receptors with labelled form of ligand in presence of test substance and measuring deg. of binding |
01/12/1994 | EP0578620A1 Pharmaceutical compositions for transdermal delivery of melatonin and/or its analogues |
01/12/1994 | EP0578535A1 New peptide derivates active in the process of cell adhesion, a method to prepare them end pharmaceutical compositions containing them |
01/12/1994 | EP0578521A1 New peptide derivatives with bradykinin-antagonistic activity, process to prepare them and pharmaceutical compositions containing them |
01/12/1994 | EP0578342A2 Purification and characterization of a CSVTCG-specific tumor cell adhesion receptor |
01/12/1994 | EP0578328A1 Production of heterodimeric human fertility hormones |
01/12/1994 | EP0578278A1 Uses of IL-1 alpha |
01/12/1994 | EP0578083A2 Cyclic adhesion inhibitors |
01/12/1994 | EP0577775A1 Anti-thrombotic peptides and pseudopeptides |
01/12/1994 | EP0577752A1 Human pf4a receptors and their use |
01/12/1994 | EP0577726A1 Fat substitute compositions having reduced laxative effects |
01/12/1994 | EP0577723A1 METHOD FOR PRODUCTION OF AN IgA BINDING PROTEIN DERIVED FROM GROUP B STREPTOCOCCI |
01/12/1994 | EP0577699A1 Compositions and methods to inhibit the activation of active factor xiii |
01/12/1994 | EP0577690A1 Organosulphur compounds useful for the treatment of glaucoma |
01/12/1994 | EP0577682A1 Small peptidic compounds useful for the treatment of glaucoma |
01/12/1994 | EP0577659A1 Cross-linking agent. |
01/12/1994 | EP0577649A1 Isolated osteogenic factor |
01/12/1994 | EP0577605A1 G protein-coupled glutamate receptors |
01/12/1994 | EP0529003B1 IgG-BINDING PROTEIN |
01/12/1994 | EP0484429B1 Method of treating infertility or sub-fertility in adult men, and the use of preparations in the method. |
01/12/1994 | EP0438531B1 Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same |
01/12/1994 | EP0423228B1 Immunoconjugates for cancer diagnosis and therapy |
01/12/1994 | EP0349654B1 Agent for prophylaxis and treatment of pancreatic disease or the like |
01/12/1994 | EP0309566B1 Stlv-iii-related polypeptides, diagnostic systems and assay methods |
01/12/1994 | CN1080658A 蛋白质c衍生物 C protein derivative |
01/11/1994 | US5278316 Indoles |
01/11/1994 | US5278297 Isolated polypeptides |
01/11/1994 | US5278290 Glycosylated |
01/11/1994 | US5278289 Purification by ionic exchanging |
01/11/1994 | US5278288 Contacting milk raw materials containing the glycomacropeptide with cation exchanger to adsorb a fraction of the material, collecting a nonadsorbed fraction, concentrating and desalting the fraction |
01/11/1994 | US5278286 Polypeptides |
01/11/1994 | US5278285 Variant of Kunitz-type inhibitor derived from the α3-chain of human type VI collagen produced by recombinant DNA technology |
01/11/1994 | US5278148 Hypotensive agents |
01/11/1994 | US5278146 Polypeptide agonist, stimulants |
01/11/1994 | US5278145 Myelotoxicity |
01/11/1994 | US5278144 Antithrombosis agents |
01/11/1994 | US5278143 Prophylactic and therapeutic methods for treating interleukin-mediated edemas |
01/11/1994 | US5278142 Systemic delivery of polypeptides through the eye |
01/11/1994 | US5278065 Genetic engineering of insertion, hybridizing |
01/11/1994 | US5278049 Gene expression vector |
01/11/1994 | US5278042 Method for detecting inhibitors of tat protein |
01/11/1994 | US5277908 Modified superoxide dismutase |
01/11/1994 | US5277907 Regulation of the immune system |
01/11/1994 | US5277903 Treating ascites in human body |
01/11/1994 | US5277893 Direct radiolabeling of substrates containing monosulfides or disulfide bonds with radionuclides |
01/11/1994 | US5277892 Administering a mixture of a lectin and a linked imaging ion |
01/11/1994 | US5277707 Air stream solvent vapor remover |
01/11/1994 | CA1326109C Sv40 expression vector containing hbxag as an expression marker |
01/11/1994 | CA1326108C Cck antagonists |
01/11/1994 | CA1326107C Heterocyclic ketones |
01/11/1994 | CA1325973C Cyclosporin-containing pharmaceutical composition |
01/06/1994 | WO1994000766A1 Gravidin: assays, dna fragments or genes and uses thereof |
01/06/1994 | WO1994000592A1 Monoclonal antibodies against glycated low density lipoprotein |
01/06/1994 | WO1994000590A1 Cloning and expression of gonadotropin-releasing hormone receptor |
01/06/1994 | WO1994000585A1 Recombinant baculoviruses containing insect cellular promoter |
01/06/1994 | WO1994000580A1 Molecular cloning of the genes reponsible for collagenase production from clostridium histolyticum |
01/06/1994 | WO1994000573A1 Novel malignant cell type markers of the interior nuclear matrix |
01/06/1994 | WO1994000571A1 Soluble cr1 derivatives |
01/06/1994 | WO1994000570A1 Mammalian growth factor |
01/06/1994 | WO1994000566A1 A thrombin blood fraction for use in a medical procedure |
01/06/1994 | WO1994000562A1 A novel human immunodeficiency virus |
01/06/1994 | WO1994000561A1 Human monoclonal anti-rhesus (d) antibodies and cell lines producing same |
01/06/1994 | WO1994000560A1 Matrix for universal donor microvascular endothelial cells |
01/06/1994 | WO1994000558A1 DIABETOGENE rad: A TYPE II DIABETES SPECIFIC GENE |
01/06/1994 | WO1994000555A2 Compositions for the inhibition of protein hormone formation and uses thereof |
01/06/1994 | WO1994000509A1 Oxazolone derived materials |
01/06/1994 | WO1994000494A1 Improvements in or relating to neuroregeneration |
01/06/1994 | WO1994000492A1 Angiotensin iv peptides and receptor |
01/06/1994 | WO1994000491A1 INTERLEUKIN-1β DELETION MUTANT |
01/06/1994 | WO1994000490A1 Nonhygroscopic crystal of aureobasidin a and production thereof |
01/06/1994 | WO1994000489A2 Radioactively-labeled somatostantin-derived peptides for imaging and therapeutic uses |
01/06/1994 | WO1994000488A1 Anti-hiv peptide or peptide derivative |
01/06/1994 | WO1994000486A1 Neuropeptide y antagonists |
01/06/1994 | WO1994000485A1 Multimeric forms of human rhinovirus receptor protein |
01/06/1994 | WO1994000484A1 Scar inhibitory factor and use thereof |
01/06/1994 | WO1994000483A1 PURIFICATION OF KRINGLE CONTAINING PROTEINS, AND ESPECIALLY t-PA |